Expanding their pipeline by linking into this agreement! This is the third or fourth agreement for more development pipeline in the last 9 months.
The lupus drug is late stage, a big market, and up front payments are small. The cost is small for now and BMRN has over 600 million in cash anyway.
This company is growing their sales and pipeline! Definate mid-sized pharma now! No baby anymore.
Kutz 
Free Forum Hosting
Important Announcement
Prev Message
New Discussion
Recommend